S-TARget therapeutics GmbH

S-TARget therapeutics is an Austrian biotech start-up company founded in August 2010. It develops novel therapeutic vaccines to cure and prevent severe, life threatening allergic diseases. The vaccines are based on a unique, proprietary technology platform and address the cause of the disease and not he symptoms. S-TARget outlicensed its platform in the field of allergy to Allergopharma/Merck in 2014.